메뉴 건너뛰기




Volumn 66, Issue 12, 2005, Pages 1537-1544

Solubilisation by emulsification: Novel formulation principle of poorly soluble drugs for intravenous administration

Author keywords

Amphotericin B; Carbamazepine; High pressure homogenisation; Itraconazole; SolEmuls

Indexed keywords

AMPHOTERICIN B; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; CARBAMAZEPINE; INTRALIPID; ITRACONAZOLE; LIPOFUNDIN; POLYSORBATE 80;

EID: 12744274624     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (22)
  • 2
    • 12744254154 scopus 로고    scopus 로고
    • Use of the Caco-2 Model to predict intestinal absorption of class III-IV drugs from different formulations
    • Funke, A. P., Petty, H. N., Backensfeld, T. et al., Use of the Caco-2 Model to predict intestinal absorption of class III-IV drugs from different formulations, Arch. Pharm. Pharm. Med. Chem. 335 (Suppl. 1), 59 (2002)
    • (2002) Arch. Pharm. Pharm. Med. Chem. , vol.335 , Issue.SUPPL. 1 , pp. 59
    • Funke, A.P.1    Petty, H.N.2    Backensfeld, T.3
  • 4
    • 0035105654 scopus 로고    scopus 로고
    • Lipid-based Amphotericin B: A review of the last 10 years of use
    • Kann, I. M., Prentice, H. G., Lipid-based Amphotericin B: a review of the last 10 years of use, Int. J. Antimicrob. Agents 17, 161 (2001)
    • (2001) Int. J. Antimicrob. Agents , vol.17 , pp. 161
    • Kann, I.M.1    Prentice, H.G.2
  • 5
    • 12744260549 scopus 로고    scopus 로고
    • Drug emulsion, Eur. Pat. 0 296 845 A1 (1988)
    • Davis, S. S., Washington, C., Drug emulsion, Eur. Pat. 0 296 845 A1 (1988)
    • Davis, S.S.1    Washington, C.2
  • 6
    • 0027478044 scopus 로고
    • Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients
    • Caillot, D., Casasnovas, O., Solary, E. et al., Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients, J. Antimicrob. Chemother. 31, 161 (1993)
    • (1993) J. Antimicrob. Chemother. , vol.31 , pp. 161
    • Caillot, D.1    Casasnovas, O.2    Solary, E.3
  • 7
    • 12744269858 scopus 로고    scopus 로고
    • Dispersions for the formulation of slightly or poorly soluble agents, DE 100 36 871.9 (2000), PCT Appl. PCT/EP01/08726 (2001)
    • Müller, R. H., Dispersions for the formulation of slightly or poorly soluble agents, DE 100 36 871.9 (2000), PCT Appl. PCT/EP01/08726 (2001)
    • Müller, R.H.1
  • 10
    • 0030927371 scopus 로고    scopus 로고
    • The use of commercially available lipid emulsions for the preparation of Amphotericin B-lipid admixtures
    • Shadkhan, Y., Segal, E., Bor, A. et al., The use of commercially available lipid emulsions for the preparation of Amphotericin B-lipid admixtures, J. Antimicrob. Chemother. 39, 655 (1997)
    • (1997) J. Antimicrob. Chemother. , vol.39 , pp. 655
    • Shadkhan, Y.1    Segal, E.2    Bor, A.3
  • 11
    • 12744273835 scopus 로고    scopus 로고
    • Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of dissolution, US Pat. 5,858,410 (1999)
    • Müller, R. H., Becker, R., Kruss, B. et al., Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of dissolution, US Pat. 5,858,410 (1999)
    • Müller, R.H.1    Becker, R.2    Kruss, B.3
  • 12
    • 12744281693 scopus 로고    scopus 로고
    • Method for controlled production of ultrafine microparticles and nanoparticles, PCT Appl. PCT/EP00/06535 (2000)
    • Müller, R. H., Mäder, K. Krause, K., Method for controlled production of ultrafine microparticles and nanoparticles, PCT Appl. PCT/EP00/06535 (2000)
    • Müller, R.H.1    Mäder, K.2    Krause, K.3
  • 13
    • 0343339969 scopus 로고    scopus 로고
    • Nanosuspensionen - Formulierung für schwerlösliche arzneistoffe mit geringer bioverfügbarkeit
    • Müller, R. H., Böhm, B. H. L., Grau, M. J., Nanosuspensionen - Formulierung für schwerlösliche Arzneistoffe mit geringer Bioverfügbarkeit, Pharm. Ind. 61, 74 (1999)
    • (1999) Pharm. Ind. , vol.61 , pp. 74
    • Müller, R.H.1    Böhm, B.H.L.2    Grau, M.J.3
  • 15
  • 16
    • 12744254153 scopus 로고    scopus 로고
    • Microprecipitation method for preparing submicron suspensions, US Pat. 6,607,784, August 19 (2003)
    • Kipp, J. E., Wong, J. C. T., Doty, M. J. et al., Microprecipitation method for preparing submicron suspensions, US Pat. 6,607,784, August 19 (2003)
    • Kipp, J.E.1    Wong, J.C.T.2    Doty, M.J.3
  • 18
    • 12744272325 scopus 로고
    • Govi-Verlag, Frankfurt/Main
    • Arzneistoff-Profile, Govi-Verlag, Frankfurt/Main (1995)
    • (1995) Arzneistoff-Profile
  • 19
    • 12744263528 scopus 로고    scopus 로고
    • Ph. D. Thessis in preparation, Free University of Berlin, Institute of Pharmacy, Biopharmaceutics and Quality Management, Berlin
    • Buttle, I., Ph. D. Thessis in preparation, Free University of Berlin, Institute of Pharmacy, Biopharmaceutics and Quality Management, Berlin
    • Buttle, I.1
  • 20
    • 0032851619 scopus 로고    scopus 로고
    • Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique
    • Yung, J. Y., Yoo, S. D., Lee, S. H. et al., Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique, Int. J. Pharm. 187, 209 (1999)
    • (1999) Int. J. Pharm. , vol.187 , pp. 209
    • Yung, J.Y.1    Yoo, S.D.2    Lee, S.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.